Association of iron deposition in MS lesion with remyelination capacity using susceptibility source separation MRI
Hyeong‐Geol Shin(Neurology, Inc), Jinhee Jang(University of Ulsan), Peter A. Calabresi(Johns Hopkins University), Yoonho Nam(The Catholic University of Korea Seoul St. Mary's Hospital), Hyunsoo Lee, Xu Li(Kennedy Krieger Institute), Jongho Lee(Seoul National University), Jung Hwan Lee(Seoul National University), Woojun Kim(National Cancer Center), Ji‐Woong Kim(Korea Research Institute of Standards and Science), Peter C.M. van Zijl(Kennedy Krieger Institute)
Cited by 4
Related Papers
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
|The Lancet|2011|743
Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis
|The Lancet Neurology|2017|572
Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial
|Nature Medicine|2000|515
Layer-specific variation of iron content in cerebral cortex as a source of MRI contrast
|Proceedings of the National Academy of Sciences|2010|433